Scinopharm Taiwan (TPE:1789) EPS (Basic) : NT$0.30 (TTM As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Scinopharm Taiwan EPS (Basic)?

Scinopharm Taiwan's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was NT$0.06. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$0.30.

Scinopharm Taiwan's EPS (Diluted) for the three months ended in Mar. 2025 was NT$0.06. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$0.30.

Scinopharm Taiwan's EPS without NRI for the three months ended in Mar. 2025 was NT$0.06. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 0.30.

During the past 12 months, Scinopharm Taiwan's average EPS without NRIGrowth Rate was -38.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was 11.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 8.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was -7.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Scinopharm Taiwan's highest 3-Year average EPS without NRI Growth Rate was 18.60% per year. The lowest was -31.20% per year. And the median was -11.60% per year.

Scinopharm Taiwan EPS (Basic) Historical Data

The historical data trend for Scinopharm Taiwan's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scinopharm Taiwan EPS (Basic) Chart

Scinopharm Taiwan Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

0.36

0.31

0.45

0.36

0.43

Scinopharm Taiwan Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															0.18	0.09	0.03	0.12	0.06

Scinopharm Taiwan EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Scinopharm Taiwan's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(339.35	-	0)	/	790.739
	=	0.43

Scinopharm Taiwan's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(46.023	-	0)	/	767.050
	=	0.06

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.30

Scinopharm Taiwan (TPE:1789) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Scinopharm Taiwan EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Scinopharm Taiwan's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Scinopharm Taiwan Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Scinopharm Taiwan Ltd (TPE:1789) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Nan-Ke 8th Road, No. 1, Southern Taiwan Science Park, Shan-Hua, Tainan, TWN, 74144

Website

https://www.scinopharm.com

Scinopharm Taiwan Ltd is a specialty and generic drug manufacturing company. The company is engaged in the manufacturing of medicines, chemicals, biological technology services, active pharmaceutical ingredients, albumin medicines, injections, and new small molecule drugs. The company also conducts consulting and technical services. The Company's sales revenue mainly arises from the manufacture and sales of Active Pharmaceutical Ingredient and injection products.

Scinopharm Taiwan Headlines

No Headlines